All In Biotech

Drug Trial Radar · NCT00002267

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

750

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
PharmaciaPfizer (PFE)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to assess the safety and the relative benefit of rifabutin monotherapy in preventing or delaying the incidence of Mycobacterium avium complex (MAC) bacteremia in AIDS patients with CD4 counts less than or equal to 200, as compared to placebo, and to assess if survival is prolonged in patients who receive rifabutin prophylaxis.

Conditions

  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections

Interventions

  • RifabutinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

43 sites in 2 countries. Site status is shown where the registry gives one.

  • Maricopa County Med Ctr

    Phoenix, Arizona

  • East Bay AIDS Ctr

    Berkeley, California

  • Pacific Oaks Med Group

    Beverly Hills, California

  • AIDS Community Research Consortium

    Redwood City, California

  • HIV Research Group

    San Diego, California

  • Dr Larry A Waites

    San Francisco, California

  • Saint Francis Mem Hosp / HIV Care

    San Francisco, California

  • Dr Marcus Conant

    San Francisco, California

  • San Francisco Veterans Administration Med Ctr

    San Francisco, California

  • Dr Marshall Kubota

    Santa Rosa, California

  • Dr Jeffrey Galpin

    Tarzana, California

  • Miami Veterans Administration Med Ctr

    Miami, Florida

  • Community Research Initiative of South Florida

    Miami, Florida

  • Northwestern Univ Med School

    Chicago, Illinois

  • AIDS Research Alliance - Chicago

    Chicago, Illinois

  • Tulane Univ School of Medicine

    New Orleans, Louisiana

  • Comprehensive AIDS Alliance of Detroit / Harper Hosp

    Detroit, Michigan

  • Univ of Minnesota

    Minneapolis, Minnesota

  • St Paul Ramsey Med Ctr

    Saint Paul, Minnesota

  • Univ of Nevada / Veterans Administration Med Ctr

    Reno, Nevada

  • North Jersey Community Research Initiative

    Newark, New Jersey

  • Univ of New Mexico Hlth Sciences Ctr / Dept of Med

    Albuquerque, New Mexico

  • Dr Donald Romig

    Sante Fe, New Mexico

  • Albany Veterans Administration

    Albany, New York

  • AIDS Services Erie County Med Ctr

    Buffalo, New York

  • Community Health Network

    Rochester, New York

  • Buckley Braffman Stern Med Associates

    Philadelphia, Pennsylvania

  • Thomas Jefferson Med College

    Philadelphia, Pennsylvania

  • Dr Alfred F Burnside Jr

    Columbia, South Carolina

  • Infectious Disease Physicians Inc

    Annandale, Virginia

  • Milwaukee County Med Complex

    Milwaukee, Wisconsin

  • Univ of Calgary Health Science Ctr

    Calgary, Alberta, Canada

  • Univ of Alberta/Division of Inf Dis/Dept of Med

    Edmonton, Alberta, Canada

  • Saint Paul's Hosp

    Vancouver, British Columbia, Canada

  • Victoria Gen Hosp

    Halifax, Nova Scotia, Canada

  • McMaster Univ Med Ctr

    Hamilton, Ontario, Canada

  • Ottawa Gen Hosp

    Ottawa, Ontario, Canada

  • Mount Sinai Hosp

    Toronto, Ontario, Canada

  • Saint Michael's Hosp

    Toronto, Ontario, Canada

  • Sunnybrook Health Science Ctr

    Toronto, Ontario, Canada

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.